biotech · Essential Tremor · Systemic Lupus Erythematosus
Chongqing Precision Biotech
Chongqing Precision Biotech Co., Ltd
Chongqing Precision Biotech is a biotech organization headquartered in Chongqing, CN. Primary therapeutic focus areas include Essential Tremor, Systemic Lupus Erythematosus, Focal Epilepsy, Multiple Myeloma, Colorectal C
Company details
- Status
- Public
- HQ
- 重庆市创业大道高科创业园A栋, Chongqing, CN
- Founded
- 2016
- Employees
- 5
- Programs
- 109
- Drugs
- 57
- Patents
- 158
PBCAR19B
Phase 1 · gene therapy · CD19 Expressing Malignancies
PBCAR19B for CD19 Expressing Malignancies is a Phase 1 program (gene_therapy) at Chongqing Precision Biotech Co., Ltd with 1 ClinicalTrials.gov record(s).
Internal code PBCAR19B-01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Chongqing Precision Biotech Co., Ltd
- Phase
- Phase 1
- Modality
- gene_therapy
- Indication
- CD19 Expressing Malignancies
- Status
- completed
- Trials
- 1